Roth MKM Initiates Coverage On Geovax Labs with Buy Rating, Announces Price Target of $20
Portfolio Pulse from Benzinga Newsdesk
Roth MKM has initiated coverage on Geovax Labs (NASDAQ:GOVX) with a Buy rating and set a price target of $20.
July 16, 2024 | 9:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Roth MKM has initiated coverage on Geovax Labs with a Buy rating and a price target of $20, indicating strong confidence in the company's future performance.
The initiation of coverage with a Buy rating and a high price target by a reputable analyst can boost investor confidence and likely lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100